This contract supports the advanced development of candidate vaccine products comprised of a vaccine component and a delivery technology, for use in post-event settings following the intentional release of a biothreat agent or naturally occurring outbreaks of infectious diseases, including biodefense pathogens such as anthrax. Such technologies are intended to simplify and expedite delivery of vaccine to large numbers of patients.

Agency
National Institute of Health (NIH)
Type
Research and Development Contracts (N01)
Project #
272201000036C-4-0-1
Application #
8654877
Study Section
Project Start
2010-08-31
Project End
2015-08-30
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$10,792,404
Indirect Cost
Name
Paxvax, Inc.
Department
Type
DUNS #
806518598
City
San Diego
State
CA
Country
United States
Zip Code
92121